Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspen Pharmacare Holdings Limited

http://www.aspenpharma.com

Latest From Aspen Pharmacare Holdings Limited

Aspen Expects Growth Following Sandoz And Viatris Deals

Aspen expects to report significant growth in its continuing operations for the first half of its financial year, following deals with Sandoz and Viatris that have seen the South African firm divest major businesses in Japan and Europe.

Sales & Earnings Deals

Viatris Sets The Bar Low So There Will Eventually Be A Chance To Grow

Viatris' 2021 financial guidance was below investor expectations, suggesting a challenging road ahead for the newly formed company.

Generic Drugs Sales & Earnings

EU Accepts Aspen Price Commitments

Commitments offered by Aspen Pharmacare last year to settle price-gouging allegations over six oncology drugs have been accepted by the European Commission.

Pricing Strategies Europe

Aspen Says Reshaping Has Been ‘Painful’ But Is Over Now

Fresh from announcing the €642m ($762m) divestment of its Thrombosis business in Europe to Mylan, Aspen Pharmacare management walked investors through its full-year earnings, explaining in detail the company’s ambitions to focus on emerging markets.

Sales & Earnings Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
  • Other Names / Subsidiaries
    • Aspen Global Incorporated (AGI)
    • Aspen Japan K.K.
UsernamePublicRestriction

Register